Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Clinical trial NCT00332969 · COMPLETED
Trial details
- NCT number
- NCT00332969
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2010-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.